Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Simeone

Showing results (221-230 of 318) with videos related to

Pageof 32
Sort By:
Vaccine|March 21, 2025
Concordance between parent-reported and documented COVID-19 vaccination status among hospitalized children and adolescents: Implications for vaccine effectiveness estimates, May 2021-October 2023Sarah Hamid, Regina M Simeone, Margaret M Newhams, et al.
ESMO Open|February 23, 2023
A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testingS Paiella, D Azzolina, D Gregori, et al.
Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.
Frontiers in Immunology|April 10, 2023
Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignanciesShanshan Wan, Ende Zhao, Daniel Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancerSameer P Desai, Edgar Ben-Josef, Daniel P Normolle, et al.
MMWR. Morbidity and Mortality Weekly Report|January 29, 2016
Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013April L Dawson, Elizabeth C Ailes, Suzanne M Gilboa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cellsWan-Ching Yen, Marcus M Fischer, Mark Hynes, et al.
Journal of Pancreatic Cancer|September 28, 2019
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus <i>nab</i>-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic CancerVaibhav Sahai, M Wasif Saif, Aparna Kalyan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancerEdgar Ben-Josef, Mathew Schipper, Isaac R Francis, et al.
Public Health Reports (Washington, D.C. : 1974)|January 7, 2023
Pregnant Women's Experiences During and After Hurricanes Irma and Maria, Pregnancy Risk Assessment Monitoring System, Puerto Rico, 2018Regina M Simeone, L Duane House, Beatriz Salvesen von Essen, et al.
Pageof 32

Showing results (221-230 of 318) with videos related to

Sort By:
Pageof 32
Vaccine|March 21, 2025
Concordance between parent-reported and documented COVID-19 vaccination status among hospitalized children and adolescents: Implications for vaccine effectiveness estimates, May 2021-October 2023Sarah Hamid, Regina M Simeone, Margaret M Newhams, et al.
ESMO Open|February 23, 2023
A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testingS Paiella, D Azzolina, D Gregori, et al.
Nature Nanotechnology|October 1, 2013
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheetsHyeun Joong Yoon, Tae Hyun Kim, Zhuo Zhang, et al.
Frontiers in Immunology|April 10, 2023
Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignanciesShanshan Wan, Ende Zhao, Daniel Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancerSameer P Desai, Edgar Ben-Josef, Daniel P Normolle, et al.
MMWR. Morbidity and Mortality Weekly Report|January 29, 2016
Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013April L Dawson, Elizabeth C Ailes, Suzanne M Gilboa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cellsWan-Ching Yen, Marcus M Fischer, Mark Hynes, et al.
Journal of Pancreatic Cancer|September 28, 2019
A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus <i>nab</i>-Paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin) in Patients with Metastatic Pancreatic CancerVaibhav Sahai, M Wasif Saif, Aparna Kalyan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancerEdgar Ben-Josef, Mathew Schipper, Isaac R Francis, et al.
Public Health Reports (Washington, D.C. : 1974)|January 7, 2023
Pregnant Women's Experiences During and After Hurricanes Irma and Maria, Pregnancy Risk Assessment Monitoring System, Puerto Rico, 2018Regina M Simeone, L Duane House, Beatriz Salvesen von Essen, et al.
Pageof 32